Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Muscle Wasting Disorders Market?

The market size for muscle wasting disorders has seen a swift expansion in the last few years. There is a projected growth from $15.06 billion in 2024 to $17.49 billion in 2025, with a compounded annual growth rate (CAGR) of 16.1%. The substantial growth observed in the past years can be linked to factors such as an increase in the aging population, a surge in chronic disease cases, advancements in R&D, heightened recognition of the importance of early diagnosis, and the emergence of novel therapeutic methods.

In the coming years, a swift expansion is anticipated in the muscle wasting disorders market. The forecast period predicts the market reaching a value of $29.52 billion in 2029, with a compound annual growth rate (CAGR) of 14.0%. Various dynamics such as regulatory backing, patient advocacy movements, improvements in healthcare infrastructure, globalization of clinical trials and personalized medicine strategies contribute to this predicted growth. The forecast period also expects a surge in telemedicine usage, technological advancements in medical diagnoses, innovations in products, enhanced collaborations and partnerships, progression in therapeutics, molecular mechanisms research, and biopharmaceutical novelties.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp

What Drivers Are Accelerating Expansion Of The Muscle Wasting Disorders Market?

The increase in people choosing a sedentary lifestyle is projected to boost the muscle wasting disorders market. The term “sedentary lifestyle” means a lifestyle characterized by physical inactivity, little or no exercise. This lack of movement can have a detrimental effect on muscle health, resulting in loss of muscle strength and endurance, promoting muscle wasting diseases and challenging the maintenance of muscular mass and functions. For example, in 2022, the Switzerland-based intergovernmental body, World Health Organization, stated that more than 80% of young people and 27% of adults do not meet the suggested levels of physical activity. Hence, the growing popularity of a sedentary lifestyle is propelling the muscle wasting disorders market.

What Are The Primary Segmentation Parameters In The Muscle Wasting Disorders Market?

The muscle wasting disordersmarket covered in this report is segmented –

1) By Treatment Type: Medications; Physical Therapy; Nutritional Therapy; Surgery; Gene Therapy; Other Treatment Types

2) By Disorder Type: Muscular Dystrophy; Amyotrophic Lateral Sclerosis (ALS); Other Disorder Types

3) By End-User: Hospitals; Rehab Centers; Specialty Clinics; Other End-Users

Subsegments:

1) By Medications: Anabolic Steroids; Hormonal Treatments; Anti-Inflammatory Drugs; Immunomodulatory Agents

2) By Physical Therapy: Resistance Training; Stretching Exercises; Aerobic Conditioning; Rehabilitation Programs

3) By Nutritional Therapy: Protein Supplements; Nutritional Counseling; Dietary Modifications; Micronutrient Supplements

4) By Surgery: Surgical Interventions For Muscle Repair; Orthopedic Surgeries; Procedures For Underlying Conditions

5) By Gene Therapy: Gene Replacement Therapy; CRISPR-Based Approaches; RNA Interference Techniques

6) By Other Treatment Types: Complementary Therapies; Psychological Support; Assistive Devices

How Are Industry Trends Steering The Expansion Of The Muscle Wasting Disorders Market?

Leading corporations in the muscle wasting disorders market are conceiving innovative solutions such as unique gene therapies to better cater to the demands of patients suffering from muscle wasting disorders. Gene therapy is a revolutionary medical breakthrough that seeks to provide treatment by altering gene expressions or modifying the biological traits of living cells. For instance, in June 2023, Sarepta Therapeutics, a renowned American biotech organization, launched Elevidys. It stands as the pioneer gene therapy to receive approval from the U.S. Food and Drug Administration (FDA) for treating Duchenne muscular dystrophy (DMD) in children ranging from 4 to 5 years old. Elevidys is a recombinant gene therapy purposed to deliver a gene into the patient’s body, which results in a shortened protein with selected constituents of the dystrophin protein found in normal muscle cells. The product is delivered as a solo intravenous infusion.

Which Players Are Shaping The Competitive Landscape Of The Muscle Wasting Disorders Market?

Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix, MyoKardia, Inc., MyoTherix Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report

What Are The Emerging Regional Trends Driving The Muscle Wasting Disorders Market?

North America was the largest region in the muscle wasting disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13706&type=smp

Browse Through More Reports Similar to the Global Muscle Wasting Disorders Market 2025, By The Business Research Company

Anorectal Disorders Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anorectal-disorders-treatment-global-market-report

Optic Nerve Disorders Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

Bleeding Disorders Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model